Vascugen is Drug Discovery in United States that focus on degenerative vascular business. Founded in 2017. They cover business area such as developer, regenerative medicine therapy, degenerative vascular and ischemic disease condition, induce pluripotent stem cell, iPSC, a pipeline, cell therapeutic, function, tissue, blood flow, enable physician, medical researcher, therapeutic payload, cardiovascular, solid tumor.
2017
( 7 years old in 2024 )
Degenerative Vascular
-
5602 Research Park Boulevard
Suite 213
Madison, WI 53719
United States
Private
developerregenerative medicine therapydegenerative vascular and ischemic disease conditioninduce pluripotent stem celliPSCa pipelinecell therapeuticfunctiontissueblood flowenable physicianmedical researchertherapeutic payloadcardiovascular, solid tumor
* We use standard office opening hours in near Vascugen's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Vascugen is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Vascugen business is focusing on Degenerative Vascular.
Vascugen headquarter office and corporate office address is located in 5602 Research Park Boulevard Suite 213 Madison, WI 53719 United States.
Vascugen was founded in United States.
In 2024, Vascugen is currently focus on degenerative vascular sector.
Above is snippet of Google Trends for "degenerative vascular" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Vascugen, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
